Stifel lowers X4 Pharmaceuticals stock price target to $7.50 from $9.00
NegativeFinancial Markets

Stifel lowers X4 Pharmaceuticals stock price target to $7.50 from $9.00
Stifel has reduced its price target for X4 Pharmaceuticals from $9.00 to $7.50, indicating a less optimistic outlook for the company's stock performance. This adjustment reflects concerns about the company's future growth and market conditions, which could impact investor confidence and trading activity. Such changes in price targets are significant as they can influence investor decisions and the overall market perception of the company.
— via World Pulse Now AI Editorial System





